Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes (ASTI)
Device: Evaluation of the impact of a guideline based computerized decision support system.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Impact of a Computerized Decision Support System, Based on EBM French Guidelines, on the Management of Hypertension and Diabetes: a Randomised Controlled Trial in Primary Care|
- Patients who underwent the recommended procedures during the last 12 months [ Time Frame: 16 months ] [ Designated as safety issue: No ]
|Study Start Date:||November 2006|
|Study Completion Date:||May 2008|
|Primary Completion Date:||January 2008 (Final data collection date for primary outcome measure)|
Existing computer-based ordering systems for physicians provide drug-centred checks but offer little assistance for optimizing the overall patient-centred treatment strategy.
The ASTI project aims :
to design a guideline-based decision support system for diabetic and/or hypertensive patients, to help general practitioners :
- to carry out procedures (clinical and biological tests) according to guidelines (the recommended procedure at the recommended moment), and to get a synthetic view of all the elements they need to follow-up the patient
- to avoid prescription errors and to improve compliance with therapeutic guidelines. The " critic mode " operates as a background process and corrects the physician's prescription on the basis of automatically triggered elementary rules that account for isolated guideline recommendations. The " guided mode " directs the physician to the best treatment by browsing a comprehensive guideline knowledge base represented as a decision tree.
- To measure the impact of ASTI when it is implemented with an electronic medical record system. We adopt a randomized design, with the practice as the unit of randomization.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00398944
|Paris, France, 75013|
|Principal Investigator:||Hector FALCOFF||Société de Formation Thérapeutique du Généraliste|